Content area
Full Text
Cigna Ventures is leading a $23 million investment in GNS Healthcare, a specialized artificial intelligence company.
Cigna Ventures is a strategic corporate venture capital partner and wholly owned indirect subsidiary of Cigna.
Joining the funding round were Amgen Ventures, Celgene, Echo Health Ventures, Alexandria Venture Investments, as well as former Caesar’s CEO and Aetna Division President Gary Loveman. The investment will back GNS and Cigna’s partnership to combine respective data, advanced analytics and machine learning to optimize Cigna’s condition-specific clinical care programs, the companies said. Oncology will be the first area of focus.
“We are thrilled to have Cigna contribute to...